1. Home
  2. WIW vs AVTX Comparison

WIW vs AVTX Comparison

Compare WIW & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Inflation-Linked Opportunities & Income Fund

WIW

Western Asset Inflation-Linked Opportunities & Income Fund

N/A

Current Price

$7.82

Market Cap

505.4M

Sector

Finance

ML Signal

N/A

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

N/A

Current Price

$6.75

Market Cap

426.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WIW
AVTX
Founded
2004
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
505.4M
426.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
WIW
AVTX
Price
$7.82
$6.75
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
★ $34.80
AVG Volume (30 Days)
330.8K
★ 2.9M
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 11.14%
N/A
EPS Growth
N/A
★ 72.07
EPS
★ N/A
N/A
Revenue
N/A
★ $27,813,137.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 2312.27
52 Week Low
$7.83
$6.53
52 Week High
$8.87
$24.27

Technical Indicators

Market Signals
Indicator
WIW
AVTX
Relative Strength Index (RSI) 34.89 33.14
Support Level N/A $6.53
Resistance Level $8.00 $8.55
Average True Range (ATR) 0.07 0.64
MACD -0.02 0.23
Stochastic Oscillator 15.71 10.40

Price Performance

Historical Comparison
WIW
AVTX

About WIW Western Asset Inflation-Linked Opportunities & Income Fund

Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income. Capital appreciation, when consistent with current income, is a secondary investment objective. The fund operates as a single operating segment, which is an investment portfolio.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Share on Social Networks: